In a speech on the eve of this year’s G-7 summit in Cornwall, England, Biden on Thursday will unveil plans for the U.S. to donate 500 million vaccine doses around the globe. Biden is expected to ask his fellow G-7 leaders to do more as well.
Tests of Pfizer’s COVID-19 vaccine started Monday in Louisiana for children ages 5 through 11.
The National Institute of Allergy and Infectious Diseases announced it has started the first phase of a trial testing whether it is safe to mix COVID-19 vaccines from different manufacturers.
Pfizer has administered its first COVID-19 booster shots. The pharmaceutical company is studying a third dose of the vaccine and a pneumococcal vaccine candidate. The first participants received their shots Monday.
We’re learning new information about Pfizer and Moderna’s vaccines, plus variants and boosters.
Federal health advisers have endorsed use of Pfizer’s COVID-19 vaccine in kids as young as 12.
Federal health officials testified before the Senate Monday, as the U.S. prepares for children to likely start getting vaccinated against the coronavirus this week. The FDA has authorized Pfizer’s vaccine for emergency use in kids ages 12-15. Now it just needs the final seal of approval from the CDC.
The FDA is expanding the emergency use authorization for the Pfizer vaccine for kids ages 12-15. CDC leaders plan to meet later this week to discuss distribution, and kids could start getting shots in arms as early as this week once the CDC director signs the agency’s recommendations.
The U.S. is expanding use of Pfizer’s COVID-19 vaccine to children as young as 12. The Food and Drug Administration said Monday the shot is safe and offers strong protection for younger teens based on testing of more than 2,000 U.S. volunteers.
This week, the Food and Drug Administration is expected to grant emergency use authorization of Pfizer’s COVID-19 vaccine for kids between 12-15 years old.
